• MJHLS Brand Logo

© 2022 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.

Incorporating New Medications into Acne Treatment

EP. 1: Acne: Who, What, and When?

December 16th 2020

As an introduction to a panel discussion on incorporating new medications into acne treatment, dermatology experts provide an overview of the who, what, and when of acne.

EP. 2: Prevalence of Acne in Adult Females

December 16th 2020

Julie C. Harper, MD, comments on the prevalence of acne in women and highlights differences from men.

EP. 3: Impact of Acne Vulgaris on Quality of Life

December 16th 2020

Dermatologists discuss the impact of acne vulgaris on the quality of life experienced by their patients.

EP. 4: Contributory and Predisposing Factors Influencing Acne

December 16th 2020

James Q. Del Rosso, DO, comments on the facts and myths surrounding contributory and predisposing factors that influence the development of acne.

EP. 5: Clinical Manifestation and Differential Diagnosis of Acne

December 16th 2020

Dermatology experts comment on the clinical manifestation of acne and the importance of differential diagnosis.

EP. 6: Common Sequelae and Potential Complications of Acne

December 16th 2020

An overview of common sequelae and potential complications of acne, including physiological and psychological scaring.

EP. 7: Selecting Treatment Based on Pathophysiology of Acne

December 16th 2020

Key opinion leaders in dermatology discuss approaches to selecting treatment based on the pathophysiology of acne.

EP. 8: Newly Approved Topical Therapy: Clascoterone Cream 1% and Micronized Tretinoin 0.05% Lotion

December 16th 2020

Dermatology experts comment on the safety and efficacy of the newly approved topical therapies clascoterone cream 1% and micronized tretinoin 0.05% lotion.

EP. 9: Newly Approved Topical Therapy: Trifarotene 0.005% Cream, Tazarotene 0.045% Lotion, and Minocycline 4% Foam

December 16th 2020

A panel of dermatology experts reviews the safety and efficacy data of the newly approved topical therapies trifarotene 0.005% cream, tazarotene 0.045% lotion, and minocycline 4% foam.

EP. 10: Newly Approved Oral Therapy: Sarecycline and Micronized Isotretinoin

December 16th 2020

During an informative discussion on current treatment options in acne, dermatology experts address the newly approved oral therapies sarecycline and micronized isotretinoin.